Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lamotrigine augmentation in unipolar depression.

Fabio Lopes Rocha1, Claudia Hara

  • 1Medical Residency of Psychiatry, Institute of Social Security of the Civil Servants of Minas Gerais, Belo Horizonte, Brazil. rochafl@uol.com.br

International Clinical Psychopharmacology
|February 25, 2003
PubMed
Summary

Lamotrigine augmentation shows promise for treatment-resistant unipolar depression, with 76% of patients improving. Further double-blind studies are needed to confirm its efficacy as an adjunctive therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can Abrupt Discontinuation of Clozapine Cause Seizures?

Psychopharmacology bulletin·2026
Same author

Inconsistent MAOI Dietary Guidance From Major AI Chatbots: A Brief Clinical Evaluation.

The Journal of clinical psychiatry·2026
Same author

A comparison between community and treatment-seeking samples of hoarding disorder.

CNS spectrums·2024
Same author

Animal hoarding: a systematic review.

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)·2023
Same author

Potential advantages of ketamine over electroconvulsive therapy in the treatment of nonrefractory severe depression in older patients with multiple medical comorbidities.

CNS spectrums·2022
Same author

Use of subcutaneous ketamine to rapidly improve severe treatment-resistant depression in a patient with Alzheimer's disease.

International clinical psychopharmacology·2020

Area of Science:

  • Psychiatry
  • Pharmacology

Background:

  • Many patients with unipolar depression do not achieve remission with standard antidepressant treatments.
  • Treatment resistance is a significant challenge in managing unipolar depression.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of lamotrigine as an augmentation strategy in patients with treatment-resistant unipolar depression.

Main Methods:

  • Retrospective chart review of patients with treatment-resistant unipolar depression.
  • Lamotrigine was used as an add-on therapy to existing antidepressant treatment.
  • Patient outcomes were assessed using the Clinical Global Impression (CGI) scale.

Main Results:

  • Seventy-six percent of patients demonstrated improvement in depressive symptoms.

Related Experiment Videos

  • No statistically significant association was found between response and patient demographics or prior treatment non-response.
  • Comorbidity appeared to be negatively associated with response to lamotrigine augmentation.

    • Conclusions:

    • Lamotrigine appears to be a promising augmentation agent for treatment-refractory unipolar depression.
    • Common side effects included somnolence, headache, dizziness, nausea, and malaise.
    • Further investigation through double-blind, placebo-controlled trials is warranted to confirm these findings.